Sponsor

ABX advanced biochemical compounds GmbH

Clinical research sponsor

Published trials6

Recruiting shown1

Roles2

SourceClinicalTrials.gov

Clinical trials

6 shown

Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate CancerNCT06122584 · lead sponsor · 2024-06-13

RECRUITING

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate CancerNCT04742361 · lead sponsor · 2021-08-27

COMPLETED

F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical RecurrenceNCT04102553 · lead sponsor · 2019-03-06

COMPLETED

Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer PatientNCT05422105 · collaborator · 2023-07-01

SUSPENDED

18F-PSMA-1007 PET Imaging to Detect Primary Prostate CancerNCT04487847 · collaborator · 2020-09-01

COMPLETED

F18-PSMA-1007 PET for Early Biochemical Recurrence of Prostate CancerNCT04239742 · collaborator · 2020-01-02

UNKNOWN

Sponsor roles

collaborator3

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.